| Single-plane (n = 128) | x-Plane (n = 128) | P | RR | 95% CI |
---|---|---|---|---|---|
IJVC | n = 87 | n = 95 |  |  |  |
 Immediate complications, n (%) | 25 (28.7%) | 10 (10.5%) | 0.002 | 0.366 | 0.187–0.718 |
 Undesired puncture | 22 (25.3%) | 8 (8.4%) | 0.002 | 0.333 | 0.157–0.709 |
 Hematoma | 7 (8.0%) | 3 (3.2%) | 0.198* | 0.392 | 0.105–1.470 |
 Posterior IJV wall puncture | 8 (9.2%) | 4 (4.2%) | 0.176 | 0.458 | 0.143–1.467 |
 Arterial puncture | 0 | 0 | - |  |  |
 Pneumothorax | 0 | 0 | - |  |  |
 Hemothorax | 0 | 0 | - |  |  |
Late complications, n (%) | 11 (12.6%) | 8 (8.4%) | 0.352 | 0.666 | 0.281–1.579 |
 Venous thrombosis | 9 (10.3%) | 3 (3.2%) | 0.051 | 0.305 | 0.085–1.091 |
 CLA-BSI | 2 (2.1%) | 0 | 0.227* |  |  |
FVC | n = 41 | n = 33 |  |  |  |
 Immediate complications, n (%) | 14 (34.1%) | 3 (9.1%) | 0.011 | 0.266 | 0.083–0.849 |
 Undesired puncture | 11 (26.8%) | 2 (6.1%) | 0.020 | 0.226 | 0.054–0.949 |
 Hematoma | 3 (7.3%) | 1 (3.0%) | 0.624* | 0.414 | 0.045–3.799 |
 Posterior FV wall puncture | 0 | 0 | - |  |  |
 Arterial puncture | 5 (12.2%) | 0 | 0.061* |  |  |
 Late complications, n (%) | 4 (9.8%) | 0 | 0.124* |  |  |
 Venous thrombosis | 2 (4.9%) | 0 | 0.499* |  |  |
 CLA-BSI | 2 (4.9%) | 0 | 0.499* |  |  |